research-az

Here is a list of all the research activity folder homepages:

Generic List

Academic Clinical Cardiovascular Medicine at City Hospital

Description
Information on the Centre for Cardiovascular Sciences at City Hospital Group, led by Professor Gregory Lip, Section of Cardiovascular Sciences, School of Clinical and Experimental Medicine, College of Medical and Dental Sciences

Accuracy of Bladder Ultrasound Study (BUS) trial

Description
Accuracy of Bladder Ultrasound Study (BUS) trial in Birmingham Clinical Trials Unit

Acute Myeloid Leukaemia and High Risk Myelodysplastic Syndrome trial 16 (AML16)

Description
Acute Myeloid Leukaemia and High Risk Myelodysplastic Syndrome trial 16 (AML16) in Birmingham Clinical Trials Unit

AD2000 Trial - A reliable assessment of the efficacy and safety of donepezil and aspirin in Alzheimer's Disease

Description
AD2000 Trial - A reliable assessment of the efficacy and safety of donepezil and aspirin in Alzheimer's Disease.

Adenovirus group

Description
Research page for the adenovirus group, run by Roger Grand and Andy Turnell, School of cancer Sciencesa, College of medical and Dental Sciences, Univesaity of Birmingham.

Adrenal Steroids, Metabolism, and Action Research Group

Description
Information on the Adrenal Steroids, Metabolism, and Action Research Group, Section of Endocrinology, Diabetes and Metabolism, School of Clinical and Experimental Medicine, College of Medical and Dental Sciences

Angiogenesis Research Group

Description
Information on the Angiogenesis Group led by Professor Roy Bicknell and Dr Victoria Heath, Section of Cardiovascular Sciences, School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, The University of Birmingham

Angioplasty and Stent for Renal Artery Lesions trial (ASTRAL)

Description
ASTRAL is a multicentre, randomized, unblinded clinical trial, comparing revascularisation in addition to medical therapy versus medical therapy alone in patients with atherosclerotic renovascular disease (ARVD). The aim of ASTRAL is to assess whether renal arterial revascularisation with balloon angioplasty and/or endovascular stenting can safely prevent progressive renal failure among patients with ARVD. ASTRAL closed to recruitment in October 2007 having recruited 806 patients, and is now in long term follow up until 2017. The trial is managed by the BCTU at the University of Birmingham.

Antimicrobial Action, Resistance and Epidemiology

Description
Members of this group work on a range of projects investigating how bacteria become resistant to antibiotics, how antibiotic resistance genes relate to the biology of pathogenic bacteria and how resistance genes are mobilised. Current research programmes focus on enteric pathogens including Escherichia coli, Salmonella and Campylobacter, respiratory pathogens including Streptococcus pneumoniae and Mycobacterium tuberculosis and nosocomial pathogens including Acinetobacter and Staphylococcus aureus. Specific interests relate to understanding the evolution of antibiotic resistance and transmission routes and dynamics of resistance as well as the study of membrane proteins in terms of resistance and the development of novel therapeutics. Research in this area is supported by extensive funding from research councils, charities, government agencies and other sources.
Displaying 1 to 10 of 371
Previous 1 2 3 4 5 Next